News & Videos - EMERGENT BIOSOLUTIONS INC.

Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic PR Newswire GAITHERSBURG, Md., Oct. 16, 2023 Professional Football Hall of Famer partners with Emergent to raise awareness of the dangers of opioid use and the importance of being prepared with NARCAN ® Nasal Spray The life-saving medicine is available over the counter nationwide, making it possible for anyone to save a life GAITHERSBURG, Md. , Oct. 16, 2023...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Emergent BioSolutions Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire NEW YORK, Aug. 8, 2023 NEW YORK , Aug. 8, 2023 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Emergent BioSolutions Inc. (NYSE: EBS). If you are a shareholder of...

Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? PR Newswire NEW YORK, Jan. 6, 2023 NEW YORK , Jan. 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SPRB, CTMX, BOXD, MGAM, and EBS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. SPRB:...

Thinking about buying stock in SIGA Technologies, Geovax Labs, Inovio Pharmaceuticals, ImmunoGen, or Emergent Biosolutions? PR Newswire NEW YORK, May 23, 2022 NEW YORK , May 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SIGA, GOVX, INO, IMGN, and EBS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. SIGA:...

Thinking about buying stock in Rivian Automotive, Siyata Mobile, Emergent Biosolutions, Stryve Foods, or IQIYI? PR Newswire NEW YORK, May 20, 2022 NEW YORK , May 20, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RIVN, SYTA, EBS, SNAX, and IQ. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. RIVN:...

SHAREHOLDER ALERT: Weiss Law Investigates Emergent BioSolutions Inc. PR Newswire NEW YORK, May 10, 2022 NEW YORK , May 10, 2022 /PRNewswire/ -- Weiss Law , a national shareholders' rights law firm, is investigating possible false claims, deceptive accounting and reporting practices, breaches of fiduciary duty, and violations of the federal securities laws by the Board of Directors and certain Company officers of Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent" or the "Company"). According to a...

SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600 PR Newswire NEW YORK, Nov. 22, 2021 NEW YORK , Nov. 22, 2021 /PRNewswire/ -- SiTime Corp. (NASD: SITM) will replace Emergent BioSolutions Inc. (NYSE: EBS) in the S&P MidCap 400, and Emergent BioSolutions will replace Domtar Corp. (NYSE: UFS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, November 30 . Paper Excellence B.V. is acquiring Domtar in a deal expected to be completed soon...

Shuman, Glenn & Stecker announces that it is investigating potential claims against certain officers and directors of Emergent BioSolutions, Inc. (“Emergent” or the “Company”) (NYSE: EBS ). Emergent is a biopharmaceutical company that develops vaccines for infectious diseases. The Firm’s investigation relates to allegations raised in a securities class action lawsuit filed against Emergent and certain of its senior officers in the U.S. District Court for the District of Maryland. The...

The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions Inc. (“Emergent BioSolutions” or “the Company”) (NYSE: EBS ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 24, 2020 and April 16, 2021, inclusive (the ''Class Period''),...

The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions Inc. (“Emergent BioSolutions” or “the Company”) (NYSE: EBS ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 24, 2020 and April 16, 2021, inclusive (the ''Class Period''),...

UPDATED DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Reminds Emergent BioSolutions Inc. Investors With Losses Over $100K of the Updated June 21 Deadline in Securities Class Action Due to the Recently Declared Federal Court Holiday - EBS PR Newswire NEW YORK, June 18, 2021 NEW YORK , June 18, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24, 2020 through April 16, 2021...

EMERGENT BIOSOLUTIONS 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc. - EBS PR Newswire NEW ORLEANS, June 17, 2021 NEW ORLEANS , June 17, 2021 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have only until June 18, 2021 to file...

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Emergent BioSolutions Inc. ("Emergent" or "the Company") (NYSE: EBS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Emergent securities between July 6, 2020 and March 31, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/ebs . This...

The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) on behalf investors who purchased or acquired Emergent common stock between April 24, 2020, and April 16, 2021 , inclusive (the “Class Period”). This action, captioned Roth v. Emergent BioSolutions Inc., et al. , Case No. 1:21-cv-01189-PX (the “ Roth Action”), was filed in the United...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS PR Newswire NEW YORK, June 16, 2021 NEW YORK , June 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Emergent and certain of its...

Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. PR Newswire RADNOR, Pa., June 8, 2021 RADNOR, Pa. , June 8, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that the firm has filed a securities fraud class action against Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") on behalf investors who purchased or acquired Emergent common stock between...

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important June 18 Deadline in Securities Class Action - EBS PR Newswire NEW YORK, June 4, 2021 NEW YORK , June 4, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24, 2020 through April 16, 2021 , inclusive (the "Class Period"), of the important June 18, 2021...

Entwistle & Cappucci LLP (“Entwistle & Cappucci” or “E&C”) today announced that the firm has filed a securities class action lawsuit on behalf of investors that purchased Emergent BioSolutions Inc.(“Emergent” or the “Company”) (NYSE: EBS) common stock from April 24, 2020 through April 16, 2021, inclusive. A copy of the complaint is available at: www.entwistle-law.com . Institutions and individuals that invested in Emergent common stock may contact E&C for additional information...

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. PR Newswire RADNOR, Pa., June 2, 2021 RADNOR, Pa. , June 2, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") investors that the firm has filed a securities fraud class action lawsuit has been filed on behalf of those who purchased or acquired Emergent...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS PR Newswire NEW YORK, June 1, 2021 NEW YORK , June 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Emergent and certain of its...